Mirzaee Vahid, Shahriari Jahanbano, Hajghani Masomeh
Department of Internal Medicine, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran.
Hematology Laboratory, Bahonar Hospital, Kerman University of Medical Sciences, Kerman, IR Iran.
Iran Red Crescent Med J. 2014 Apr;16(4):e12458. doi: 10.5812/ircmj.12458. Epub 2014 Apr 5.
CCR5 is a receptor for CCL3 (MIP-1 α), CCL4 (MIP-1 α) and CCL5 (regulated on activation normal T cell expressed and secreted (RANTES)) and play important roles in recruitment of NK cells to the HBV infected liver.
The main purpose of this study was to investigate the expression levels of CCR5 on the NK cells and also serum levels of RANTES in chronic HBV infected (CHI) patients.
In this descriptive study 63 CHI patients and 96 healthy controls were evaluated regarding CCR5 expression on the NK cells and serum levels of RANTES using flow cytometry and ELISA techniques, respectively. Real-Time PCR technique also was used for HBV-DNA quantification.
The results revealed that CCR5 expressing NK cells and serum levels of RANTES were decreased significantly in the CHI patients in compare to healthy control.
Based on the results it can be concluded that NK cells of Iranian CHI patients are unable to express adequate levels of CCR5 and expression levels of RANTES by immune cells also are defected in CHI patients, hence, the migration of NK cells to the infected hepatocytes and HBV eradication from the cells is interrupted.
CCR5是CCL3(MIP-1α)、CCL4(MIP-1β)和CCL5(活化正常T细胞表达和分泌调节因子(RANTES))的受体,在自然杀伤细胞(NK细胞)募集到乙肝病毒感染的肝脏过程中发挥重要作用。
本研究的主要目的是调查慢性乙肝病毒感染(CHI)患者中NK细胞上CCR5的表达水平以及血清中RANTES的水平。
在这项描述性研究中,分别使用流式细胞术和酶联免疫吸附测定(ELISA)技术评估了63例CHI患者和96例健康对照者NK细胞上CCR5的表达及血清中RANTES的水平。实时聚合酶链反应(PCR)技术也用于乙肝病毒DNA定量分析。
结果显示,与健康对照相比,CHI患者中表达CCR5的NK细胞及血清RANTES水平显著降低。
基于这些结果可以得出结论,伊朗CHI患者的NK细胞无法表达足够水平的CCR5,免疫细胞中RANTES的表达水平在CHI患者中也存在缺陷,因此,NK细胞向受感染肝细胞的迁移以及从细胞中清除乙肝病毒的过程被中断。